SCHEMBL17423720

SCHEMBL17423720

N#Cc1ccc(Oc2cccnc2)cn1

nearest known ligand 0.68

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 0.68
ALDH1A1 P00352 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CYP11B1 P15538 1/20 0.55
CYP11B2 P19099 1/20 0.55
LMNA P02545 2/20 0.55
TDP1 Q9NUW8 1/20 0.55
LTA4H P09960 2/20 0.50
HTT P42858 1/20 0.43
GRM5 P41594 3/20 0.43
MAP4K4 O95819 1/20 0.42
MKNK1 Q9BUB5 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1681065 0.84 CYP19A1 (0.50) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL11473119 0.82 CYP19A1 (0.49) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL2194408 0.82 CYP19A1 (0.66) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL31528097 0.81 CYP19A1 (1.00) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL2023479 0.81 CYP19A1 (1.00) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL16114401 0.79 LMNA (0.75) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL676142 0.79 LMNA (0.82) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL30535283 0.79 LMNA (0.82) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL13889297 0.78 CYP19A1 (0.56) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL522790 0.77 CYP19A1 (1.00) CYP19A1ALDH1A1SMN1; SMN2CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016007837-A1 CARBONYL LINKED BICYCLIC HETEROARYL ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-01-14 WO disclosed
WO-2016007837-A1 CARBONYL LINKED BICYCLIC HETEROARYL ANTIBIOTIC TOLERANCE INHIBITORS SPERO THERAPEUTICS, INC. (US) 2016-01-14 WO disclosed